highthroughput
screen
ht
integr
drug
discoveri
process
multipl
assay
format
wide
use
mani
differ
diseas
area
limit
focu
infecti
agent
recent
year
increas
number
ht
campaign
use
infecti
wildtyp
pathogen
rather
surrog
biochem
pathogenderiv
target
concurr
enhanc
emerg
pathogen
surveil
increas
human
mobil
result
increas
emerg
dissemin
infecti
human
pathogen
seriou
public
health
econom
social
implic
global
level
adapt
ht
drug
discoveri
process
biocontain
laboratori
develop
new
drug
previous
uncharacter
highli
pathogen
agent
feasibl
ht
higher
biosafeti
level
bsl
present
number
uniqu
challeng
ht
conduct
multipl
bacteri
viral
pathogen
pilot
screen
recent
extend
environ
nipah
ebola
virus
recent
success
effort
demonstr
ht
safe
conduct
highest
level
biolog
contain
review
outlin
specif
issu
must
consid
execut
ht
drug
discoveri
program
highcontain
pathogen
present
overview
requir
ht
highlevel
biocontain
laboratori
h
ighthroughput
screen
ht
cornerston
modern
drug
discoveri
wide
use
pharmaceut
academ
field
ht
process
use
screen
infecti
pathogen
modern
biosafeti
requir
adapt
ht
oper
biosafetylevel
bsl
laboratori
biocontain
environ
appropri
specif
pathogen
biosafeti
regulatori
requir
pathogen
research
tremend
impact
design
execut
ht
campaign
infecti
agent
studi
describ
modif
standard
ht
process
allow
us
identifi
potenti
therapeut
candid
pathogen
four
laboratori
biosafeti
level
activ
involv
infecti
microorgan
laboratori
anim
specifi
center
diseas
control
prevent
cdc
tabl
design
level
order
degre
protect
addit
degre
protect
confer
bsl
increas
level
protect
cumul
provid
personnel
environ
commun
enhanc
worker
safeti
environment
protect
address
perceiv
actual
risk
work
pathogen
agent
requir
increas
level
contain
activ
involv
infecti
pathogen
requir
standard
microbiolog
practic
common
laboratori
evolv
time
may
perform
facil
exceed
biocontain
agentspecif
minimum
safeti
regulatori
complianc
evolut
ht
facil
discoveri
therapeut
infecti
pathogen
occur
past
decad
larg
result
miniatur
autom
robot
commerci
avail
custom
biolog
safeti
cabinet
bsc
specif
design
contain
ht
equip
construct
new
govern
programsponsor
highbiocontain
laboratori
ht
tradit
perform
larg
footprint
autom
equip
prevent
inclus
insid
bsc
bsc
use
preserv
steril
cultur
cell
use
assay
contain
infecti
pathogen
protect
oper
ht
highbiocontain
laboratori
requir
inclus
import
logist
oper
factor
adher
addit
regulatori
oversight
requir
delin
select
agent
rule
cdc
biosafeti
microbiolog
biomed
laboratori
bmbl
usda
guidelin
mani
infecti
diseas
screen
program
make
use
phenotyp
assay
broad
antimicrobi
drug
discoveri
employ
replicationcompet
pathogen
assay
compound
physiolog
relev
cellbas
model
decad
ago
ht
oper
use
infecti
pathogen
infrequ
autom
dispens
compound
cell
infecti
agent
done
use
convent
liquid
handler
biomek
fig
compli
biosafeti
requir
ensur
steril
cellular
assay
instrument
hous
bsc
specif
modifi
accommod
weight
size
commerci
avail
type
instrument
limit
adopt
ht
key
step
drug
discoveri
process
motiv
instrument
manufactur
develop
mani
new
type
dispens
better
suit
use
biocontain
laboratori
earli
infecti
diseas
ht
effort
directli
adapt
manual
antivir
antimicrobi
assay
format
conduct
micropl
autom
lowthroughput
step
exampl
manual
procedur
specifi
eukaryot
cell
dispens
assay
plate
incub
overnight
allow
form
attach
monolay
addit
test
compound
addit
compound
assay
plate
transport
bsc
addit
viru
process
involv
move
assay
plate
incub
multipl
time
alter
plate
temperatur
media
ph
contribut
increas
assay
variabl
addit
provid
multipl
opportun
plate
mishandl
eg
accid
drop
plate
contribut
reduc
biosafeti
addit
commerci
avail
reagent
rapid
assay
endpoint
also
limit
earli
ht
reagent
allow
cellbas
assay
endpoint
develop
singl
step
ie
add
read
avail
endpoint
frequent
cell
viabil
base
util
mt
similar
reagent
requir
plate
handl
ad
addit
time
process
due
factor
throughput
use
process
limit
less
plate
compound
per
day
success
infecti
diseas
ht
campaign
provid
ideal
start
point
test
modif
process
goal
make
assay
oper
streamlin
effici
laboratori
process
improv
reagent
develop
add
read
endpoint
larg
liquid
handler
replac
smallfootprint
portabl
noncontact
dispens
fig
next
process
improv
came
miniatur
cellbas
assay
micropl
simultan
reduc
reagent
use
increas
throughput
next
improv
chang
order
compound
reagent
addit
predrug
assay
readi
plate
arp
prepar
ad
dilut
compound
well
ad
cell
follow
pathogen
minim
delay
arp
streamlin
process
infecti
pathogen
assay
point
batch
approxim
one
hundr
micropl
compoundsday
could
prepar
minim
plate
manipul
increas
assay
reliabl
robust
process
streamlin
antivir
assay
combin
host
cell
viru
dispens
assay
plate
cell
control
ad
use
separ
dispens
method
use
screen
larg
number
assay
contain
laboratori
minim
number
plate
manipul
screen
addit
cell
control
cell
plu
viru
combin
singl
dispens
step
separ
reservoir
cell
mix
cell
viru
prepar
ad
plate
singl
pass
separ
one
line
dispens
cassett
head
use
cell
control
balanc
line
use
dispens
cell
plu
viru
mixtur
figur
compar
two
plate
layout
next
process
improv
prepar
arp
could
store
extend
period
time
use
plate
could
frozen
ship
store
need
process
requir
nanolit
volum
compound
dmso
dispens
plate
initi
pin
tool
use
process
variabl
problem
method
develop
acoust
liquid
handler
allow
arp
prepar
tempor
spatial
apart
assay
set
much
greater
accuraci
process
instrument
improv
brought
infecti
pathogen
screen
level
effici
support
ht
laboratori
addit
effici
improv
involv
use
highdens
frozen
cell
stock
reagent
bacteri
antivir
assay
process
use
stock
cryopreserv
cell
directli
assay
allevi
cell
cultur
variabl
due
passag
cultur
variabl
cell
use
directli
frozen
stock
prepar
expand
cell
cultur
larg
number
flask
passag
cell
harvest
concentr
rate
frozen
store
vapor
phase
liquid
nitrogen
use
assay
perform
frozen
cell
singl
passag
provid
uniform
biolog
respons
throughout
extend
screen
campaign
without
variabl
come
multipl
cell
cultur
prepar
method
use
support
batch
run
sever
hundr
plate
cell
per
day
possibl
use
cryopreserv
cell
prefer
method
cell
suppli
streamlin
process
reduc
variabl
cost
howev
cryopreserv
cell
work
cell
type
assay
ht
center
success
run
screen
use
cryopreserv
cell
cell
respiratori
syncyti
viru
rsv
assay
vero
cell
nipah
viru
assay
cell
work
directli
frozen
stock
includ
cell
therefor
import
evalu
cryopreserv
cell
direct
use
monitor
cell
viabil
assay
plate
layout
compound
librari
plate
contain
compound
column
row
ap
indic
yellow
column
empti
accommod
assay
control
antivir
screen
compound
transfer
assay
plate
dmso
ad
control
well
cell
control
ad
column
one
dispens
cell
plu
viru
mix
togeth
ad
column
anoth
dispens
screen
process
simplifi
compon
could
ad
one
dispens
singl
pass
format
illustr
b
one
line
dispens
head
use
dispens
cell
cell
control
well
row
b
remain
line
separ
reservoir
contain
cell
viru
mix
togeth
dispens
remaind
plate
includ
test
compound
viru
control
well
b
growth
comparison
made
antivir
assay
valid
ensur
assay
perform
consist
whether
use
frozen
cultur
cell
process
improv
implement
laboratori
gradual
acquir
ht
capabl
although
need
biosafeti
spacelimit
person
protect
equip
ppe
like
continu
affect
throughput
laboratori
mean
quit
like
biocontain
laboratori
may
never
see
ultraht
perform
level
biochem
laboratori
achiev
ht
personnel
rapidli
becom
accustom
work
biocontain
environ
necessari
screen
broad
rang
live
pathogen
special
oper
consider
requir
ht
highcontain
laboratori
summar
far
right
column
tabl
addit
regulatori
biosafeti
requir
oper
process
ht
high
contain
must
thoroughli
establish
ensur
highqual
repeat
result
sinc
biocontain
oper
directli
involv
live
pathogen
difficult
timeconsum
restrict
reason
design
program
allow
major
oper
perform
lowest
requir
biocontain
level
oper
done
lower
biocontain
typic
includ
noninfecti
step
cell
reagent
prepar
compound
librari
manipul
data
analysi
step
requir
high
biocontain
includ
direct
work
pathogen
assay
prepar
assay
incub
data
acquisit
requir
pair
least
two
dedic
laboratori
global
ht
effort
first
laboratori
laboratori
prepar
reagent
cell
need
assay
materi
well
compound
manipul
plate
second
laboratori
laboratori
work
infecti
pathogen
take
place
tabl
list
stage
process
design
execut
separ
task
type
contain
addit
consider
laboratori
engin
control
biosafeti
oper
equip
requir
ppe
restrict
data
control
discuss
noncontact
liquid
dispens
dispos
remov
dispens
cartridg
use
facilit
decontamin
decontamin
liquid
channel
chemic
mean
difficult
valid
effici
use
remov
liquid
channel
cartridg
advantag
highcontain
environ
cartridg
dispos
discard
chemic
decontamin
without
concern
carryov
chemic
decontamin
next
assay
wellmat
thermo
matrix
hudson
nh
smallfootprint
noncontact
liquid
dispens
dispos
cartridg
use
micropl
format
cartridg
featur
flexibl
design
easili
modifi
dispens
multipl
solut
plate
simultan
enabl
addit
variou
reagent
singl
pass
extens
evalu
sever
ht
effort
wellmat
cartridg
dispens
tip
separ
tension
mechan
allow
dispens
tip
remov
holder
place
reservoir
decontamin
solut
extern
decontamin
tip
assembl
remov
instrument
provid
addit
safeti
oper
cartridg
consid
dispos
need
chemic
decontamin
wash
extens
remov
chemic
decontamin
remov
instrument
dispens
head
bag
autoclav
reus
cassett
head
limit
number
autoclav
cycl
dispens
accuraci
affect
facil
autoclav
set
achiev
higher
temperatur
decontamin
wast
autoclav
temperatur
affect
dispens
head
perform
quickli
taken
consider
select
dispens
use
biocontain
instrument
nondispos
dispens
head
multidrop
combi
dispens
thermo
scientif
waltham
abl
dispens
micropl
format
cartridg
instrument
consid
dispos
still
remov
autoclav
effici
decontamin
addit
dispens
tip
integr
part
tension
assembl
make
difficult
extern
decontamin
dispens
tip
compound
prepar
convent
liquid
handler
dispos
tip
use
extens
ht
recent
use
acousticbas
dispens
liquid
contact
becom
avail
exampl
echo
acoust
dispens
labcyt
sunnyval
ca
use
sound
wave
dispens
nl
droplet
sourc
destin
plate
acoust
dispens
use
prepar
arp
ht
campaign
also
use
dispens
bacteria
motil
assay
viru
particl
quantit
polymeras
chain
reaction
qpcr
unpublish
data
howev
like
larg
complex
liquid
handler
suitabl
use
due
size
servic
limit
engin
control
play
critic
role
prevent
releas
pathogen
agent
highcontain
laboratori
control
ventil
laboratoryneg
air
pressur
air
curtain
provid
bsc
facil
hepa
filtrat
provid
one
effect
engin
control
use
ht
equip
typic
affect
global
airflow
within
laboratori
size
locat
equip
potenti
disrupt
local
airflow
exampl
autom
ht
liquid
handler
dispens
use
prepar
assay
plate
dispens
pathogencontain
solut
gener
aerosol
oper
therefor
must
contain
within
bsc
place
larg
piec
equip
insid
bsc
two
major
factor
must
consid
first
bsc
must
larg
enough
complet
contain
equip
still
provid
reason
work
space
insid
cabinet
second
size
equip
decreas
oper
level
protect
disrupt
air
curtain
provid
bsc
preserv
engin
control
highcontain
ht
laboratori
readili
accomplish
use
wider
deeper
bsc
instead
width
extra
depth
equip
reduc
space
requir
small
footprint
modular
laboratori
design
mobil
equip
benchtop
maximum
process
flexibl
move
larg
heavi
piec
equip
fix
bench
creat
opportun
accid
exposur
contain
laboratori
mobil
workstat
larger
equip
like
plate
reader
facilit
move
equip
airlock
move
instrument
contain
laboratori
decontamin
equip
remov
biocontain
laboratori
work
pathogen
biosafeti
regulatori
complianc
must
review
oper
minim
risk
work
infecti
agent
includ
agentspecif
train
rout
transmiss
incub
period
sign
symptom
diseas
prophylaxi
therapi
effect
decontamin
procedur
use
autom
ht
equip
highcontain
laboratori
creat
differ
set
risk
manual
oper
need
specif
address
ensur
safeti
addit
instrumentspecif
train
includ
proper
equip
oper
troubleshoot
decontamin
safeti
issu
associ
autom
devic
motor
driven
move
part
potenti
physic
injuri
use
improperli
work
highbiocontain
laboratori
oper
train
extens
use
ident
equip
safeti
paramount
highcontain
laboratori
chang
process
andor
equip
need
evalu
environ
implement
high
contain
addit
agentspecif
train
flexibl
facilitiesspecif
train
also
necessari
ht
oper
biocontain
laboratori
oper
use
firm
guidelin
rule
govern
regulatori
agenc
specifi
requir
pathogen
mani
laboratori
oper
variabl
depend
natur
work
pathogen
util
affect
ppe
oper
wear
time
allow
oper
stay
laboratori
without
exit
rest
decontamin
procedur
remov
item
sampl
equip
laboratori
exampl
experiment
bacillu
anthraci
requir
oper
wear
respir
experiment
highli
pathogen
avian
influenza
requir
oper
wear
power
airpurifi
respir
papr
along
addit
train
engin
control
enhanc
biosafeti
cost
effort
requir
movement
materi
equip
highcontain
laboratori
dedic
ht
equip
longterm
perman
use
insid
biocontain
facil
highli
desir
sinc
avoid
frequent
decontamin
movement
equip
contain
facil
method
decontamin
requir
equip
expos
extend
period
time
h
highli
reactiv
corros
chemic
vapor
destruct
microbi
life
chemic
exposur
also
destruct
electron
compon
optic
therefor
decontamin
cycl
kept
minimum
avoid
shorten
life
valuabl
equip
routin
equip
mainten
often
perform
factorytrain
servic
profession
mani
factori
servic
profession
bar
medic
surveil
biosecur
restrict
refus
enter
highcontain
facil
equip
must
remov
high
contain
decontamin
mainten
repair
critic
factor
select
equip
use
highcontain
laboratori
larg
devic
difficult
move
complex
instrument
need
frequent
servic
support
equip
must
instal
servic
engin
suitabl
use
contain
laboratori
small
robust
instrument
maintain
repair
oper
better
choic
applic
physic
move
equip
site
oper
also
mean
must
requir
servic
person
set
oper
minim
equip
damag
decontamin
preserv
routin
mainten
schedul
facil
ht
equip
decontamin
mainten
equip
often
coordin
regulatoryrequir
annual
shutdown
facil
allow
servic
personnel
safe
enter
facil
equip
remov
facil
mainten
addit
train
advanc
equip
mainten
given
highcontain
laboratori
staff
troubleshoot
repair
equip
need
realtim
camera
clear
view
equip
well
network
instrument
comput
assist
experienc
technic
personnel
direct
troubleshoot
oper
outsid
contain
secur
reason
may
limit
type
access
oper
requir
addit
ppe
reduc
risk
oper
accident
infect
common
addit
ppe
item
work
includ
respiratori
protect
mask
papr
dispos
multilay
garment
addit
glove
boot
scrub
dispos
suit
gown
work
complet
barrier
protect
pressur
suit
extern
suppli
air
requir
figur
illustr
chang
ppe
requir
oper
safeti
select
equip
use
contain
laboratori
compat
requir
ppe
preserv
manual
dexter
choos
glove
much
heavier
standard
laboratori
latex
nitril
glove
visibl
display
instrument
insid
bsc
display
instrument
obstruct
place
bsc
hear
oper
wear
papr
isol
suit
audibl
signal
may
loud
enough
hear
due
nois
produc
ppe
import
consider
enhanc
level
ppe
make
difficult
oper
precis
potenti
affect
experiment
result
increas
oper
risk
impact
ppe
offset
rigor
oper
train
instil
patienc
attent
detail
experiment
consequ
experi
requir
extend
time
high
contain
greater
care
necessari
conduct
oper
frequent
limit
period
laboratori
exit
oper
usual
may
requir
lengthi
experi
altern
experiment
time
must
shorten
pars
account
oper
fatigu
ht
oper
requir
electron
transfer
data
point
acquisit
databas
storag
process
accomplish
local
area
network
lan
transfer
data
within
organ
internet
transfer
data
organ
transfer
data
contain
laboratori
lan
usual
accomplish
hard
wire
connect
wireless
transmitt
penetr
concret
wall
hous
type
facil
data
secur
concern
manag
organ
inform
technolog
group
data
retriev
contain
laboratori
process
use
standard
bioinformat
method
govern
regulatori
agenc
mandat
rule
regul
govern
work
laboratori
take
coordin
effort
institut
environment
health
safeti
staff
biosafeti
committe
facil
manag
respons
investig
maintain
updat
program
compli
current
regul
exampl
local
institut
biosafeti
committe
frequent
charter
oversight
approv
biosafeti
oper
well
includ
earli
possibl
process
guidanc
approv
ht
process
within
laboratori
institut
biosafeti
committe
may
differ
interpret
bmbl
requir
andor
wish
add
addit
layer
safeti
oper
could
affect
ht
oper
contain
biosafeti
oversight
exampl
might
handl
microtit
plate
contain
infecti
materi
move
bsc
anoth
locat
incub
plate
reader
within
contain
laboratori
may
involv
seal
surfac
decontamin
plate
remov
bsc
use
secondari
contain
transport
unseal
plate
assay
plate
need
remov
fig
amount
person
protect
equip
ppe
increas
bsl
oper
class
ii
biosafeti
cabinet
shown
differ
ppe
describ
tabl
shown
level
oper
shown
manipul
smallfootprint
noncontact
liquid
dispens
contain
facil
ibc
eh
personnel
involv
determin
proper
decontamin
process
requir
could
affect
qualiti
result
andor
number
plate
process
within
work
day
one
compliant
solut
seal
microtit
plate
surfac
decontamin
bsc
read
plate
reader
requir
plate
reader
capabl
bottom
read
assay
endpoint
optic
clear
seal
use
stacker
use
pose
safeti
risk
plate
jam
insid
instrument
requir
decontamin
add
complex
instrument
increas
instrument
time
increas
servic
call
laboratori
space
within
high
contain
highli
constrain
limit
number
peopl
piec
equip
room
make
standard
procedur
increas
throughput
duplic
equip
andor
increas
personnel
either
extrem
costli
imposs
achiev
comput
wide
use
control
laboratori
equip
collect
data
possibl
remot
access
comput
technic
support
remot
locat
done
routin
use
webex
cisco
san
jose
ca
use
softwar
like
pcanywher
symantec
mountain
view
ca
allow
access
comput
purpos
troubleshoot
softwar
equip
problem
train
personnel
physic
access
comput
extrem
power
technolog
quickli
resolv
technic
problem
prevent
fail
screen
run
inform
secur
concern
might
also
prohibit
remot
access
comput
insid
contain
facil
make
data
transfer
equip
troubleshoot
repair
difficult
final
duplic
equip
outsid
contain
laboratori
allow
technic
personnel
train
best
use
troubleshoot
equip
without
restrict
impos
work
high
contain
contain
highest
level
biocontain
reserv
danger
exot
biolog
agent
pose
high
individu
risk
aerosoltransmit
laboratori
infect
lifethreaten
diseas
worker
may
present
high
risk
spread
commun
usual
effect
prophylaxi
treatment
avail
pathogen
primarili
hemorrhag
encephalit
fever
virus
ebola
marburg
nipah
current
immens
global
pressur
conduct
therapeut
research
discoveri
virus
combat
current
epidem
condit
endem
area
world
expans
ht
laboratori
would
greatli
aid
task
howev
oper
laboratori
present
greatest
challeng
ht
effort
infecti
pathogen
circumv
need
conduct
ht
laboratori
number
strategi
employ
enabl
screen
primarili
includ
use
surrog
attenu
virus
pseudotyp
virus
screen
base
noninfecti
viruslik
particl
vlp
minigenom
replicon
system
strategi
enabl
ht
perform
pathogen
facil
access
laboratori
concern
artifici
system
may
accur
reflect
antivir
target
virul
pathogen
work
histor
low
throughput
reli
visual
observ
cytopath
effect
cpe
quantit
viru
titer
plaqu
assay
qpcr
manual
process
scalabl
level
throughput
need
conduct
ht
campaign
recent
highcont
imag
use
ebola
vlp
screen
compound
librari
sever
pathogen
actual
imag
sampl
conduct
requir
extens
fixat
sampl
inactiv
viru
remov
contain
highcont
screen
hc
fulli
adapt
due
difficulti
maintain
complex
instrument
high
contain
need
process
sampl
remov
contain
laboratori
therefor
develop
highthroughput
bioassay
employ
infecti
replicationcompet
wildtyp
pathogen
environ
would
signific
advanc
would
remark
streamlin
hasten
drug
discoveri
process
multipl
report
autom
ht
perform
singl
report
true
autom
ht
assay
biocontain
repres
paradigm
shift
drug
discoveri
highli
pathogen
infecti
agent
done
possibl
screen
hundr
thousand
compound
week
antivir
activ
use
actual
pathogen
lower
throughput
nonautom
assay
report
format
fulli
adapt
autom
ht
typic
platform
previous
incorpor
assay
perform
follow
remov
plate
subsequ
analysi
viru
replic
howev
remov
plate
high
biocontain
requir
rigor
decontamin
assay
plate
cell
fixat
viru
inactiv
compromis
result
addit
number
manipul
transfer
microtit
plate
make
method
logist
impract
process
larg
number
plate
process
autom
recent
nipah
viru
cellbas
assay
use
implement
semiautom
ht
platform
goal
produc
assay
capabl
screen
compound
per
run
effort
collabor
southern
research
sr
galveston
nation
laboratori
gnl
part
univers
texa
medic
branch
galveston
platform
allow
screen
wildtyp
viru
strain
instead
pseudotyp
surrog
recombinantli
attenu
virus
downgrad
use
lower
biocontain
level
throughput
ht
assay
consider
greater
previou
report
assay
use
pathogen
screen
smallmolecul
compound
singledos
format
hit
compound
concentrationdepend
respons
per
run
platform
provid
rapid
drug
evalu
hit
identif
character
defin
ec
select
valu
potenti
antivir
therapeut
tabl
outlin
step
undertaken
perform
gener
ht
assay
contain
laboratori
step
discuss
ht
nipah
viru
assay
phenotyp
screen
inhibitor
cpe
induc
vero
cell
nipah
viru
infect
endpoint
cell
viabil
luminesc
onestep
detect
reagent
use
initi
process
procedur
safeti
consider
submit
institut
biosafeti
committe
organ
review
approv
risk
assess
pathogen
respect
transmiss
type
contain
requir
within
perform
accord
regulatori
requir
ppe
worn
oper
pressur
suit
fig
provid
signific
level
protect
approv
met
actual
develop
optim
assay
evalu
flow
work
outlin
undertaken
initi
step
involv
gnl
laboratori
personnel
travel
sr
extens
train
could
conduct
use
simpl
mainten
equip
reciproc
sr
ht
center
supervisor
travel
gnl
overse
set
use
equip
use
mock
assay
pathogen
run
locat
sr
gnl
equip
move
liquid
handl
equip
dispens
viru
cell
dilut
drug
plate
place
bsc
howev
space
restrict
plate
reader
read
endpoint
kept
outsid
bsc
inher
risk
plate
drop
becom
jam
reader
plate
seal
bsc
surfac
decontamin
read
therefor
combin
plastic
adhes
seal
ppe
bsc
train
act
suffici
barrier
accident
exposur
protect
barrier
place
next
step
establish
screen
defin
optim
flow
work
fig
restrict
work
contain
requir
simplifi
assay
design
minim
plate
handl
facil
arp
prepar
sr
plate
seal
frozen
ship
gnl
dri
ice
contain
facil
remain
compon
ad
singl
pass
minim
plate
handl
viru
cell
mix
dispens
use
flexibl
noncontact
liquid
handl
system
class
ii
bsc
within
laboratori
accomplish
dispens
vero
cell
control
one
reservoir
use
one
line
dispens
dispens
cell
mix
viru
anoth
reservoir
use
remain
dispens
line
plate
layout
illustr
figur
plate
incub
day
equilibr
room
temperatur
min
equal
volum
endpoint
reagent
ad
plate
incub
addit
min
room
temperatur
seal
surfac
decontamin
read
plate
reader
luminesc
mode
gnl
work
flow
plate
prepar
analyz
group
first
plate
per
run
test
process
actual
condit
attempt
increas
throughput
howev
valid
process
ht
laboratori
complet
project
plate
per
run
process
effect
use
two
oper
translat
compound
per
run
run
per
week
assay
nipah
screen
financi
rather
logist
constraint
limit
number
compound
screen
nipah
unpublish
ebola
pilot
ht
project
adapt
ht
environ
success
pilot
screen
two
differ
viru
pathogen
creat
opportun
true
ht
effort
ebola
nipah
virus
one
first
step
tradit
drug
discoveri
program
also
mean
strategi
could
appli
pathogen
lassa
crimean
congo
hemorrhag
fever
junin
virus
addit
highli
pathogen
emerg
virus
look
ahead
throughput
ht
assay
conduct
highcontain
laboratori
could
improv
go
higher
densiti
microtit
plate
place
current
use
version
bacteri
yeast
assay
conduct
micropl
format
shortterm
viral
assay
also
potenti
done
format
could
implement
higher
contain
laboratori
throughput
need
new
technolog
present
opportun
bring
differ
type
assay
ht
infecti
agent
multimod
plate
reader
use
monitor
wide
varieti
endpoint
includ
fluoresc
absorb
fluoresc
polar
luminesc
proximitybas
endpoint
like
fluoresc
reson
energi
transfer
alphascreen
timeresolv
fluoresc
reson
energi
transfer
use
highcont
imag
recent
incorpor
ht
process
moreov
possibl
contain
laboratori
practic
current
gener
hc
instrument
higher
level
contain
laboratori
instrument
larg
requir
signific
servic
support
impract
laboratori
practic
laser
scan
cytomet
perform
mani
hcstype
assay
use
small
robust
instrument
difficult
manag
multimod
plate
reader
almost
fast
instrument
like
ttp
acumen
mirrorbal
molecular
devic
velo
fall
categori
mirrorbal
uniqu
laser
scan
cytomet
narrow
field
focu
enabl
platebas
fac
elisa
style
assay
nowash
format
instrument
use
monitor
cell
surfac
express
viral
protein
addit
antibodi
specif
viral
protein
interest
directli
assay
plate
follow
addit
fluoresc
label
secondari
antibodi
plate
imag
laser
scan
cytomet
detect
cellassoci
fluoresc
measur
viral
infect
done
without
fix
step
wash
step
also
use
monitor
viru
infect
spread
gfp
express
viru
unpublish
data
enabl
technolog
allow
develop
ht
assay
virus
produc
cpe
modifi
express
report
gene
also
use
monitor
express
fluoresc
protein
engin
virus
cell
line
expand
type
assay
appli
antivir
drug
discoveri
anoth
technolog
becom
common
ht
applic
qpcr
use
secondari
assay
monitor
mrna
level
compoundtr
cell
sr
ht
center
qpcr
technolog
also
use
quantifi
number
viru
particl
directli
supernat
taken
infect
cell
provid
way
monitor
viru
titer
reduct
assay
endpoint
develop
underway
adapt
technolog
qpcr
format
screen
laboratori
highcontain
laboratori
format
may
practic
limit
might
high
enough
throughput
ht
campaign
would
power
counter
screen
compound
identifi
type
assay
describ
recent
outbreak
ebola
viru
underscor
import
vaccin
drug
develop
emerg
highli
pathogen
agent
abil
respond
rapidli
robust
drug
discoveri
effort
critic
respond
emerg
pathogen
develop
antivir
drug
anticip
drugresist
strain
pathogen
emerg
henc
continu
drug
discoveri
effort
need
possibl
conduct
ht
campaign
highest
level
biocontain
capabl
present
opportun
modern
drug
discoveri
method
appli
deadli
pathogen
world
recent
ongo
outbreak
ebola
viru
infect
west
africa
underscor
need
develop
therapeut
pathogen
fastest
way
use
proven
methodolog
modern
drug
discoveri
difficulti
limit
work
process
review
demonstr
done
drug
discoveri
develop
expens
even
expens
work
highlevel
contain
laboratori
greatest
barrier
success
limit
regul
work
contain
procur
financi
resourc
work
need
produc
therapeut
